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Abstract The effectiveness of cognitive rehabilitation
(CR) in Parkinson’s disease (PD) is in its relative infancy,
and nowadays there is insufficient information to support
evidence-based clinical protocols. This study is aimed at
testing a validated therapeutic strategy characterized by
intensive computer-based attention-training program tai-
lored to attention deficits. We further investigated the
presence of synaptic plasticity by means of functional
magnetic resonance imaging (fMRI). Using a randomized
controlled study, we enrolled eight PD patients who
underwent a CR program (Experimental group) and seven
clinically/demographically-matched PD patients who
underwent a placebo intervention (Control group). Brain
activity was assessed using an 8-min resting state (RS)
fMRI acquisition. Independent component analysis and
statistical parametric mapping were used to assess the
effect of CR on brain function. Significant effects were
detected both at a phenotypic and at an intermediate phe-
notypic level. After CR, the Experimental group, in
comparison with the Control group, showed a specific
enhanced performance in cognitive performance as asses-
sed by the SDMT and digit span forward. RS fMRI ana-
lysis for all networks revealed two significant groups
(Experimental vs Control) 9 time (T0 vs T1) interaction
effects on the analysis of the attention (superior parietal
cortex) and central executive neural networks (dorsolateral
prefrontal cortex). We demonstrated that intensive CR
tailored for the impaired abilities impacts neural plasticity
and improves some aspects of cognitive deficits of PD
patients. The reported neurophysiological and behavioural
effects corroborate the benefits of our therapeutic approach,
which might have a reliable application in clinical man-
agement of cognitive deficits.
Keywords Parkinson’s disease  Cognitive
rehabilitation  Attention deficits  Resting-state fMRI 
Parieto-prefrontal cortex
Introduction
Although Parkinson’s disease (PD) is considered a motor
control disorder, global cognitive function deteriorations
represent a common complication, occurring approxi-
mately in 40 % of cases [1]. Cognitive impairment in PD
patients is mainly characterized by executive deficits,
which is characterized by loss of concentration, difficulties
in logic reasoning, long-term and procedural memory dis-
turbances, visuospatial deficits and executive dysfunction
encompassing difficulty in planning, organizing and regu-
lating goal-directed behaviour [2].
It is well known that cognitive decline has a deleterious
impact on quality of life of patients with PD, even beyond
that from physical disability alone. Given this effect, the
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alleviation of such deficit should become an imperative for
PD research and practice. In fact, the amelioration of
cognitive deficits may improve everyday functioning in
PD, thus greatly reducing the impact of the disease on the
lives of people with PD and the overall cost of the disease
to society at large. To date, there are no definitive phar-
macological treatments for cognitive dysfunctions in PD.
In the last few years, cognitive rehabilitation (CR) has
shown the potential to reduce disability and improve
quality of life in individuals with neurological disorders
(stroke, head trauma or multiple sclerosis) and their care-
givers [3, 4].
Despite the need for CR services as a standard of care,
there is a paucity of research studies designed to investigate
treatment approaches for patients with PD. Indeed,
research on the effectiveness of CR in PD is in its relative
infancy, and nowadays there is insufficient information to
support evidence-based clinical protocols. However, in the
last few years, some studies have evaluated symptomatic
treatments for cognitive dysfunction in PD, and pre-
liminary results have been promising [5–7]. The few
existing CR programmes within PD have been aimed at
improving overall frontal functions (attention, working
memory, calculation, memory, visuospatial abilities).
Although these studies had shown a common beneficial
effect in treated PD patients, they were characterized by
heterogeneous rehabilitative approaches and some meth-
odological limitations. Indeed, only one study was a dou-
ble-blind randomized, controlled trial [7].
For this reason, this study is aimed at determining the
impact of a tailored intervention to improve or restore
impaired attention functions in PD patients with predomi-
nant attention deficits using a robust statistical design. The
idea of a neurorehabilitation program tailored to a specific
cognitive deficit has proven very promising in treating other
neurodegenerative disorders [5, 8]. Although this approach
restricts sample selection, it eliminates potential confound-
ers linked to the presence of additional cognitive impair-
ments and thus helps with the interpretation of the results.
Moreover, to better delineate the effectiveness of our pro-
posed method, we investigated the underlying functional
activity of associative brain areas by using resting state (RS)
functional magnetic resonance imaging (fMRI), which rep-
resents a very sensible tool to explore subtle active processes
of neuroplasticity that might be driven by CR [8].
Methods
Subjects
One hundred and thirty-seven case patients with clinical
diagnoses of PD according to the United Kingdom PD
Society Brain Bank criteria [9] were consecutively selected
among the outpatients of the Institute of Neurology of the
University ‘‘Magna Graecia’’ of Catanzaro, Italy. From this
initial cohort we enrolled only PD patients who fulfilled the
following criteria: (1) no presence of dementia, according
to the DSM-IV criteria; (2) predominant deficits in either
attention and/or information processing speed, working
memory and/or executive functioning [i.e., failure of at
least one of the following tests: symbol digit modality test
(SDMT), Trial Making Test (TMT A–B), Paced Auditory
Serial Addition Test (PASAT), digit span forward and
backward and Stroop word-colour task (ST), see below];
(3) no additional impairment in other cognitive domains
(i.e. language, verbal and spatial long-term memory); (4)
no evidence of motor complications (i.e., levodopa-induced
dyskinesias); (5) no history of psychiatric problems,
according to the structured clinical interview of the DSM-
IV; (6) no evidence of vascular brain lesions, brain tumour
and/or marked brain atrophy on MRI scan and (7) no
movement artefacts during MRI exam. The clinical
assessment included Hoehn–Yahr (HY) staging and unified
Parkinson’s disease rating scale (UPDRS) scores. Written
informed consent (approved by the Ethical Committee of
the University ‘Magna Graecia’ of Catanzaro) were col-
lected from all subjects enrolled in the study.
From the initial group, 117 PD patients were excluded.
Specifically, 30 patients were characterized by dementia;
27 patients were not demented but were, however, char-
acterized by additional cognitive deficits (i.e. language
dysfunctions); 30 patients had other additional motor
complications incompatible with MRI examination (i.e.
dyskinesias); 15 patients had additional psychiatric com-
plications (i.e. major depression or gambling); eight
patients were characterized by additional vascular lesions
and seven MRI exams were removed due to exaggerated
movement artefacts. For this reason, 20 PD patients satis-
fied inclusion criteria and were enrolled in the study. All
PD patients were treated with levodopa. Additional treat-
ments were ropinirole (one patient in Experimental group
and two patients in the controls group) and pramipexole
(two patients in Experimental group and two patients in the
controls group).
Neuropsychological assessment
All patients completed an extensive battery of neuropsy-
chological tests [10] assessing:
(a) Spatial memory: the Rey–Osterrieth Complex Figure
Test (ROCFT), which assesses immediate and
delayed recall (IR and DR).
(b) Verbal memory: the Selective Reminding Test (SRT),
which assesses verbal learning and DR. It also
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includes a list of 12 words and uses six consecutive
learning trials and a delayed trial (SRT-long-term
storage and SRT-consistent long-term retrieval
(CLTR).
(c) Visuospatial processing: Judgment Line Orientation
Test (JLO).
(d) Verbal fluency: Controlled Oral Word Association
Test (COWAT).
(e) Sustained attention and information processing speed:
SDMT and PASAT.
(f) To test additional attention abilities and executive
functions (such as executive control and task switch-
ing) not explored by the BRB, we also included the
digit span forward/backward, ST and TMT form A–B.
Cognitive performances were recorded at baseline and after
6 weeks (using form A and B to avoid learning effects).
Finally, we further investigated the mood status using the
beck depression inventory, the state-trait anxiety inventory
(STAI) and aspects of well-being using the Parkinson’s
Disease Questionnaire (PDQ-39) [11].
Design and procedures
The proposed CR approach has recently been validated [3].
Our study was a blind, randomized, controlled trial divided
into four principal stages. The first stage was based on the
recruitment of the patients for the study. The patients were
not informed about their group assignment or the rationale
behind their training performed in our clinic (Experimental
group) or at home (Control group). In the second stage, the
eligible PD patients underwent MRI examination (T0).
Neuropsychological and MRI examinations were per-
formed in the ON phase of medication. In the third stage,
subjects were randomly assigned to two groups. The
Experimental group met twice a week for 1-h sessions for
six consecutive weeks. Sessions consisted of computer-
assisted training of several attention ability and information
processing tasks. Attention training was performed using
the package RehaCom (http://www.Schuhfried.at) (for
more information see [3]). The Control group underwent a
similar exposure to computerized tests, consisting of 12
individual 1-h sessions over a six-week period. In partic-
ular, the Control group performed a simple visuomotor
coordination tapping task by using an in-house software.
Finally, at the end of the 6-week training, subjects from
both groups were given a blind evaluation, using the same
protocol employed at a baseline (T1). Two PD patients
from the Experimental group and three from the Control
group decided not to continue with the protocol. Thus,
eight PD patients from the Experimental group and seven
PD patients from the Control group completed the protocol
(Fig. 1).
Resting state fMRI acquisition and analysis
Scanning was performed on a 3-T scanner (MR750 General
Electric, USA). A gradient-echo planar (EPI) T2*-weigh-
ted pulse sequence (TR = 2,000 ms, TE = 25 ms, number
of axial slices = 39, thickness/gap = 3/0.8 mm, matrix
size = 96 9 96) was employed. A total of 200 volumes
were acquired for a total imaging time of 7 min. During the
functional scan, subjects were asked to simply stay
motionless, awake and relaxed with their eyes closed.
Image preprocessing
Group spatial independent component analysis (ICA) was
performed using FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/)
and Group ICA for fMRI (http://mialab.mrn.org/software/).
Group ICA was constituted by three main stages: data
reduction, ICA, and back reconstruction. Individual sub-
jects’ data were first reduced by principal components
analysis (PCA), next concatenated, and finally reduced
again by another PCA step. ICA was then applied to this
latter reduced data set. The resulting components reflected
group components across all subjects.
Within-group and between-group comparisons for each
resting state network (RSN) with potential functional
Fig. 1 Flow diagram of subject recruitment and participation in the
study. The experimental group participated in an individualized CR
program for attention deficits (Rehacom software); the control group
received motor therapy re-education (placebo intervention)
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relevance was assessed using SPM8. ANOVA model was
used for performing a group (Experimental vs Con-
trol) 9 time (T0 vs T1) interaction analysis, in order to
detect which within-group changes of RS functional
activity over time were significant between groups. The
head motion parameters were also included as nuisance
covariates. Based on previous findings, we decided to use
the dorso-lateral prefrontal cortex, ventro-lateral prefrontal
cortex, anterior cingulate cortex, superior and inferior
parietal lobule, caudate and the whole-cerebellum as a
priori regions of interest (ROIs) given their critical
engagement on attention abilities and executive functions
[12]. All ROIs were created with the ‘‘aal.02’’ atlas
included in the Wake Forest University Pickatlas software
version 1.04 (http://www.fmri.wfubmc.edu/download.
htm). Statistical analyses within ROIs were thresholded by
using correction for multiple comparisons [family-wise
error (FWE) p \ 0.05].
Statistical analysis
Statistical analyses were performed with Statistica Version
6.0 (http://www.statsoft.com). Assumptions for normality
were tested (using Kolmogorov–Smirnov test) for all
continuous variables. All variables were normally distrib-
uted, except for educational level, HY and equivalent dose
of levodopa. Unpaired t test, Mann–Whitney U test and v2
were applied appropriately. Behavioural changes associ-
ated with CR therapy were calculated as differential T1–T0
(delta) scores. All statistical analyses had two-tailed alpha
levels of \0.05 for defining significance.
Results
Clinical and neuropsychological findings
At the time of inclusion, the two groups were perfectly
matched for all demographical and clinical variables (see
Table 1). At baseline, there were no significant differences
between the Experimental group and the Control group in
any of the neuropsychological tests (all p’s [ 0.05)
(Table 2). During the re-test phase any clinical or radio-
logical change was detected in the patients. At a pheno-
typic level, the differential T1–T0 (delta) scores for each
neuropsychological test were compared between the
Experimental and Control groups (Table 3). Overall,
considering all cognitive and psychological domains,
after CR the Experimental group showed significant cog-
nitive improvements in the SDMT (T-value = 4.1,
p-level = 0.04) and the digit span forward (T-value = 9.3,
p-level = 0.01).
RS fMRI
The analysis of RS fMRI detected ten spatial maps of
potentially relevant RSNs, including those related to
Table 1 Participant’s characteristics
Variables Experimental
group
Control
group
p values
Age (years) 61.1 ± 12.4 58.3 ± 9.6 0.24
Education (years) 8 (3–13) 8 (3–10) 0.88§
Age at onset (years) 58.1 ± 12.3 54.9 ± 15.3 0.11
Disease duration (years) 3.5 ± 0.8 3.2 ± 1 0.38
UPDRS 16.8 ± 8 17.2 ± 2.9 0.79
HY 2 (1–3) 2 (1–3) 0.91§
Levodopa (mg/die) 375 (250–600) 420 (200–600) 0.34§
Data are given as mean values (SD) or median values (range) when
appropriate
Unpaired t test
§ Mann–Whitney test
HY Hoehn–Yahr
UPDRS unified Parkinson’s disease rating scale
Table 2 Neuropsychological performances in the Experimental and
Control groups at baseline
Tests Baseline (T0)
Experimental group Control group Statistics
Mean SD Mean SD p-values
SRT-LTS 33.3 5.6 38.2 9.1 0.27
SRT-CLTR 25.5 11.5 33.1 8.8 0.22
SRT-D 5.7 2.2 5.7 1.6 0.14
ROCFT IR 17.5 6.2 15.4 8.7 0.63
ROCFT DR 18 6.4 15.1 7.1 0.47
COWAT 31.6 8.2 36 9.3 0.73
PASAT 300 33.3 4.1 38.5 11.6 0.28
SDMT 34.54 11.5 36.2 7.4 0.78
TMT A 51.43 8 43.8 15.3 0.28
TMT B 125.43 69.4 123.8 64.8 0.97
TMT B-A 74.6 57.1 101 42 0.54
ST 18.3 7.2 25.1 6.5 0.13
Digit span FW 4.14 1 6.1 0.2 0.08
Digit span BW 3.9 1.2 3.6 0.9 0.69
JLO 23.6 3.5 23.2 3.5 0.41
Beck II 5.86 4.1 8.9 4.7 0.28
Stai-Y1 40.1 12.1 46.4 10 0.36
Stai-Y2 41.4 11.3 40.6 9.7 0.91
PQD-39 40.5 20.7 40.3 25.1 0.99
MMSE 28.7 1.5 29.4 0.5 0.37
Italic means SD values
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sensorimotor areas, primary and secondary visual cortical
areas, primary and secondary auditory areas, default mode
network, salience processing network, attention function
network and central executive networks (left and right
sides) (Fig. 2) [13]. All these components were stable
across multiple runs of IC decomposition.
Group 9 time interaction effects
Considering the interaction effects between groups
(Experimental vs Control group) 9 time (T0 vs T1), after
CR the Experimental group demonstrated significantly
increased intrinsic functional activity in the left dorso-
lateral prefrontal cortex within the left central executive
RSN when compared to Control group (MNI local max-
ima: x = -46, y = 50, z = 4, F = 10.5, PFWE = 0.04).
Again, an additional significant functional change was
detected in the left superior parietal lobule within the
attention RSN (MNI local maxima: x = -18, y = -70,
z = 52, F = 12.2, PFWE = 0.03) (Fig. 3). No significant
group 9 time interaction was found for other RSNs
examined.
Table 3 Neurocognitive performances and measures of functional scales in the Experimental and Control groups at baseline and retest
Tests Baseline (T0) Re-test (T1) Delta (T1–T0) Statistics
Experimental
group
Control
group
Experimental
group
Control
group
Experimental
group
Control
group
p-values
Mean SD Mean SD Mean SD Mean SD
Verbal memory
SRT-LTS 33.3 5.6 38.2 9.1 35 6.9 39.37 10.1 1.7 1.12 0.92
SRT-CLTR 25.1 11.5 33.1 8.8 28.9 5.8 32.9 12.5 3.86 -0.24 0.56
SRT-D 5.7 2.2 5.7 1.6 6.96 2.3 7.8 1.2 1.3 0.24 0.39
Spatial memory
ROCFT IR 17.5 6.2 15.4 8.7 21.7 8.1 19.3 10.4 4.16 3.92 0.95
ROCFT DR 18 6.4 15.1 7.1 22.64 6.5 19.1 9.5 4.64 4.06 0.85
Verbal fluency
COWAT 31.6 8.2 36 9.3 34.83 8.4 36.8 6.5 3.23 0.8 0.59
Information processing speed/attention/executive functions
PASAT 300 33.3 4.1 38.5 11.6 37.7 5 43.9 10.6 4.43 5.4 0.79
SDMT 34.54 11.5 36.2 7.4 43.1 17.6 35 10.2 8.51 21.12 0.04
TMT A 51.43 8 43.8 15.3 48.14 9.4 42 15.2 -3.29 -1.8 0.76
TMT B 125.43 69.4 123.8 64.8 114.71 43.5 97.8 25.4 -10.7 -26 0.44
TMT B-A 74.6 57.1 101 42 70.43 41.5 74.8 22.9 -4.1 -26.2 0.36
ST 18.3 7.2 25.1 6.5 20.1 11.6 23.02 3.7 1.86 -2.1 0.16
Digit span FW 4.14 1 6.1 0.2 5.9 0.9 5.7 0.4 1.81 20.5 0.01
Digit span BW 3.9 1.2 3.6 0.9 4.6 1.5 4 1 0.7 0.4 0.68
Visuospatial processing
JLO 23.6 3.5 23.2 3.5 24.6 2.6 24.6 2.6 1 -1 0.29
Mood
Beck II 5.86 4.1 8.9 4.7 5.7 6.4 8.7 4.7 -0.1 -1.4 0.61
STAI-Y1 40.1 12.1 46.4 10 43.1 13.4 42.2 8.3 3 -4.2 0.24
STAI-Y2 41.4 11.3 40.6 9.7 37.7 11.9 40.8 12.7 -3.7 0.2 0.46
Quality of life
PDQ-39 40.5 20.7 40.3 25.1 38.1 15.3 44.8 21.5 -2.38 2.73 0.61
General cognition
MMSE 28.7 1.5 29.4 0.5 29.16 1.1 29.6 0.5 0.43 0.2 0.57
Italic means SD values
Bold values represent significant statistical differences (p \ 0.05)
SRT-LTS Selective Reminding Test-long term storage, SRT-CLTR Selective Reminding Test-consistent long term retrieval, SRT-D Selective Reminding
Test-delayed, ROCFT Rey–Osterrieth Complex Figure Test [immediate and delayed recall (IR/DR)], COWAT Controlled Oral Word Association Test,
SDMT Symbol Digit Modalities Test, PASAT-3 Paced Auditory Serial Addition Test-3s, ST Stroop Test, TMT Trial Making Test A–B, JLO Judgment
Line Orientation Test, STAI state-trait anxiety inventory Y1 and Y2, PDQ-39 Parkinson’s Disease Questionnaire, MMSE Mini Mental State Examination
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Discussion
The results of the current study are perfectly in line with
the reported beneficial effects of CR in other neurological
diseases or acquired brain injuries [3, 4, 14]. The proposed
therapeutic approach is part of a recent trend to tailor
neurorehabilitation programs to a specific cognitive deficit.
In fact, recent studies demonstrated that when CR is
focused on a specific cognitive domain, significantly
positive results are achieved in neurological patients [3,
14]. Apart from the improvement in specific cognitive
functions, a strength of this study is the employment of
functional neuroimaging, which allows us to confirm that
an intensive computer-based training of attention abilities
yields adaptive neural plasticity of associated neural
networks.
In particular, RS fMRI analysis revealed the presence of
a functional reorganization in specific brain regions: the
dorso-lateral prefrontal cortex and superior parietal lobule.
A large amount of evidence demonstrated that the dorso-
lateral prefrontal cortex and posterior parietal cortex are
essential for executive functions, particularly in working
memory (i.e. keeping spatial information in memory over a
short time period). Maintenance and storage are the prin-
cipal processes required to sustain working memory ability.
While storage and buffering have been associated with
parietal cortex activities, the dorso-lateral prefrontal cortex
has been proposed as a crucial node supporting mainte-
nance processes [12]. Thus, the detected over-activity of
the parieto-prefrontal pathway would seem to suggest that
our proposed therapeutic strategy acts in recovering spe-
cific mechanisms of plasticity (read cognitive strategies) in
PD patients, which might help to decrease the emergence
of cognitive impairment. Although the exact nature of the
processes leading to a cortical over-activation is still
unknown, these increased responses have been interpreted
as ‘compensatory mechanisms’ that would have required
an increased ‘cognitive effort’ to achieve a normal level of
behavioural performance. Of note, the detected cognitive
improvements in the SDMT and digit span forward,
Fig. 2 Spatial maps of
cognitively functional relevant
RSNs from the cohort of PD
patients (one sample t-contrast
thresholded for positive values;
p \ 0.05 FWE corrected for
multiple comparisons)
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perfectly agree with the reported neural changes. In fact,
either the SDMT or digit span forward are simple and
relatively short tasks that emphasize the speed of infor-
mation processing and short-term working memory abili-
ties. Moreover, both tasks have been demonstrated to be
strongly dependent upon the recruitment of the frontopa-
rietal neural activity [15, 16].
One main study limitation was its relatively small sample
size owing to the difficulty in enrolling PD patients with
either a predominant attention deficit or a clinical condition
compatible with neuroimaging examination. The fact that
we have enrolled only 20 PD patients with predominant
attention deficits from our large initial group confirms the
difficulty in investigating the neural correlates of CR in PD
patients and highlights that our findings could not be gen-
eralized to all PD populations. Therefore, to sustain the
usefulness of our CR therapy for minimizing the emergence
of cognitive impairments in PD patients, further studies are
warranted employing a larger sample that consider patients
with additional cognitive deficits. Despite this methodo-
logical limitation, several major strengths distinguish
this study. First, our blind, randomized, controlled trial
design ensured internal validity of the results. Second, the
reported functional changes survived conservative statis-
tical thresholds. Third, based on previous investiga-
tions, we conducted a validated intensive training program
to improve behavioral outcomes in neurological patients
[3, 14].
In conclusion, our study confirms the beneficial effect of
the proposed CR strategy focused on attention disorders
because attention represents a controlling and integrating
function with implications for nearly all other cognitive
systems. These findings might represent an important
improvement in this research field, since almost all previ-
ous works generally employed non-specific interventions
where a plethora of cognitive functions were rehabilitated
[5–7]. In fact, when CR is tailored on one specific cognitive
domain, significant and more effective results may be
found in the PD population.
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